Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine.

Simone de Vries Lentsch,Britt W H van der Arend,Irene de Boer,Erik W van Zwet,Antoinette MaassenVanDenBrink,Gisela M Terwindt

European journal of neurology（2023）

引用 0|浏览3

暂无评分

摘要

Anti-CGRP (ligand or receptor) monoclonals lead to improvement of depressive symptoms in individuals with migraine, independent of migraine reduction. Depression may predict treatment response to erenumab but not to fremanezumab.

查看译文

关键词

depression, migraine, predictor, treatment response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要